International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e608-e612 , July 2010

Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006–2007

  • Junjie Xu

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • Key Laboratory of Immunology of AIDS, Ministry of Health, First Hospital of China Medical University, Shenyang, China
    • ,
  • Haibo Wang

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • ,
  • Yan Jiang

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • ,
  • Guowei Ding

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • ,
  • Manhong Jia

      Affiliations

    • Yunnan Center for Disease Control and Prevention, Yunnan, China
    • ,
  • Guixiang Wang

      Affiliations

    • Kaiyuan Center for Disease Control and Prevention, Kaiyuan, China
    • ,
  • Jennifer Chu

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • ,
  • Kumi Smith

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • ,
  • Gerald B. Sharp

      Affiliations

    • National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD, USA
    • ,
  • Ray Y. Chen

      Affiliations

    • National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD, USA
    • ,
  • Xia Jin

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • ,
  • Ruiling Dong

      Affiliations

    • Health Care Center of Shenzhen International Travel, Shenzhen Entry-Exit Inspection and Quarantine Bureau, China
    • ,
  • Xiaoxu Han

      Affiliations

    • Key Laboratory of Immunology of AIDS, Ministry of Health, First Hospital of China Medical University, Shenyang, China
    • ,
  • Hong Shang

      Affiliations

    • Key Laboratory of Immunology of AIDS, Ministry of Health, First Hospital of China Medical University, Shenyang, China
    • Corresponding Author InformationCo-corresponding author.
    • ,
  • Ning Wang

      Affiliations

    • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing, China
    • Corresponding Author InformationCorresponding author at: National Center for AIDS/STDs Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xuanwu District, Beijing 10050, PR China. Tel.: +86 10 6303 9093; fax: +86 10 6303 9093.

Received 4 March 2009 ,Revised 1 September 2009 ,Accepted 7 September 2009.

References 

  1. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18:295–307
  2. Rehle T, Shisana O, Pillay V, et al. National HIV incidence measures: new insights into the South African epidemic. S Afr Med J. 2007;97:194–199
  3. Nesheim S, Parekh B, Sullivan K, et al. Temporal trends in HIV type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses. 2005;21:537–544
  4. McDougal JS, Parekh BS, Peterson ML, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses. 2006;22:945–952
  5. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520–529
  6. Hu DJ, Vanichseni S, Mock PA, et al. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. AIDS Res Hum Retroviruses. 2003;19:727–730
  7. Sinthuwattaniwibool C, Wasinrapee P, Chaowanachan T, et al. Application of the BED-CEIA to a cohort of military conscripts in northern Thailand to estimate HIV-1 incidence: a validation study. Abstract No. 731. 12th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, USA, February 22-25, 2005.
  8. Hargrove JW, Humphrey JH, Mutasa K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS. 2008;22:511–518
  9. Bulterys M, Parekh BS, Chao A, et al. Use of an IgG capture BED enzyme immunoassay to investigate recent HIV-1 seroconversions among young women in Rwanda: comparison with 24-month prospective cohort data. Abstract No. MoPeC3458. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004.
  10. Kim AA, Parekh B, Marum L, et al. Can HIV incidence be estimated from cross-sectional serologic surveys in Africa: novel application of a new HIV incidence laboratory assay. 55th Annual Epidemic Intelligence Service Conference, Georgia, USA. Available at: http://www.cdc.gov/EIS/conference/archives/EIS%20Booklet_11.pdf (accessed December 2009).
  11. The United Nations Joint Programme on HIV/AIDS (UNAIDS). Statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Report of a meeting of the UNAIDS Reference Group for Estimates, Modelling and Projections, Athens, Greece, December 13-15, 2005. Geneva: UNAIDS; 2005.
  12. Karita E, Price M, Hunter E, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS. 2007;21:403–408
  13. Centers for Disease Control and Prevention. Interim recommendations for the use of the BED capture enzyme immunoassay for incidence estimation and surveillance. Atlanta, GA: CDC, Office of the Global AIDS Coordinator; 2006;
  14. Wang N. HIV epidemic in China and the World—current situation and challenges. Science Technology and Review. 2005;23:4–8
  15. Jiang Y, Wang MJ, Ni MJ, et al. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS. 2007;21(Suppl. 8):S47–S51
  16. Han M, Wang YL, Wang MJ, et al. Application of BED-CEIA to estimate the human immunodeficiency virus prevalence among injecting drug users in Chongqing municipality. Chinese J Epidemiol. 2007;28:1077–1080
  17. Xiao Y, Jiang Y, Feng JG, et al. Measuring recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immunol. 2007;14:1384–1386
  18. Yang R, Xia X, Kusagawa S, et al. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS. 2002;16:1401–1407
  19. Buchacz K, Klausner JD, Kerndt PR, et al. HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syndr. 2008;47:234–240
  20. Wang HB, Chen YR, Ding GW, et al. Prevalence and predictors of HIV infection among female sex workers in Kaiyuan City, Yunnan Province, China. Int J Infect Dis. 2008;19:365–369
  21. Hayashida T, Gatanaga H, Tanuma J, et al. Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses. 2008;24:495–498

PII: S1201-9712(09)00368-3

doi: 10.1016/j.ijid.2009.09.004

International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e608-e612 , July 2010

Article Tools